Cancer Letters
Natural killer cells for pancreatic cancer immunotherapy: Role of nanoparticles
Publication date: Available online 2 November 2023Source: Cancer LettersAuthor(s): Virender Kumar, Ram I. Mahato
Cancer Letters
Claudin-1 interacts with EPHA2 to promote cancer stemness and chemoresistance in colorectal cancer
Publication date: Available online 2 November 2023Source: Cancer LettersAuthor(s): Mark Primeaux, Xiangdong Liu, Saiprasad Gowrikumar, Iram Fatima, Kurt W. Fisher, Dhundy Bastola, Alex J. Vecchio, Amar B. Singh, Punita Dhawan
Cancer Letters
Setd2 deficiency promotes gastric tumorigenesis through inhibiting the SIRT1/FOXO pathway
Publication date: Available online 31 October 2023Source: Cancer LettersAuthor(s): Wenxin Feng, Chunxiao Ma, Hanyu Rao, Wei Zhang, Changwei Liu, Yue Xu, Rebiguli Aji, Ziyi Wang, Jin Xu, Wei-Qiang Gao, Li Li
Cancer Letters
Histone lactylation-derived LINC01127 promotes the self-renewal of glioblastoma stem cells via the <em>cis</em>-regulating the MAP4K4 to activate JNK pathway
Publication date: Available online 29 October 2023Source: Cancer LettersAuthor(s): Lulu Li, Ziwei Li, Xiangqi Meng, Xinyu Wang, Dan Song, Yuxiang Liu, Tianye Xu, Jie Qin, Nan Sun, Kaifu Tian, Junzhe Zhong, Daohan Yu, Yu Song, Tianlang Hou, Chuanlu Jian…
Cancer Letters
CTRP6 protects against ferroptosis to drive lung cancer progression and metastasis by destabilizing SOCS2 and augmenting the xCT/GPX4 pathway
Publication date: Available online 29 October 2023Source: Cancer LettersAuthor(s): Songhua Cai, Baohui Zhang, Chujian Huang, Youjun Deng, Chunguang Wang, Yikun Yang, Zichang Xiang, Yao Ni, Zhe Wang, Lixu Wang, Baihua Zhang, Xiaotong Guo, Jie He, Kai Ma…
Cancer Letters
Precise delivery of celastrol by PEGylated aptamer dendrimer nanoconjugates for enormous therapeutic effect via superior intratumor penetration over antibody counterparts
Publication date: Available online 26 October 2023Source: Cancer LettersAuthor(s): Boning Niu, Yuehuang Wu, Min Zhou, Ruimiao Lin, Pengjin Ge, Xiaohui Chen, Hu Zhou, Xiaokun Zhang, Jingjing Xie
Cancer Letters
SETD4 inhibits prostate cancer development by promoting H3K27me3-mediated NUPR1 transcriptional repression and cell cycle arrest
Publication date: Available online 24 October 2023Source: Cancer LettersAuthor(s): Chong Wang, Tao Wang, Kang-Jing Li, Ling-Hong Hu, Yue Li, Yu-Zhong Yu, Tao Xie, Sha Zhu, Du-Jiang Fu, Yang Wang, Xian-Zi Zeng, Feng-Ping Liu, Hong Chen, Zhe-Sheng Chen, …
Cancer Letters
Compound AC1Q3QWB upregulates CDKN1A and SOX17 by interrupting the HOTAIR—EZH2 interaction and enhances the efficacy of tazemetostat in endometrial cancer
Publication date: Available online 20 October 2023Source: Cancer LettersAuthor(s): Lingli Chen, Xingyu Zheng, Wenlu Liu, Yiqing Sun, Shuangshuang Zhao, Lina Tian, Wenyan Tian, Fengxia Xue, Chunsheng Kang, Yingmei Wang
Cancer Letters
LINC00926 promotes progression of renal cell carcinoma via regulating miR-30a-5p/SOX4 axis and activating IFNγ-JAK2-STAT1 pathway
Publication date: Available online 20 October 2023Source: Cancer LettersAuthor(s): Lin Du, Baojun Wang, Mengtong Wu, Weixu Chen, Wendi Wang, Wenli Diao, Meng Ding, Wei Chen, Wenmin Cao, Hongqian Guo, Gutian Zhang
Cancer Letters
<em>Ganoderma microsporum</em> immunomodulatory protein as an extracellular epidermal growth factor receptor (EGFR) degrader for suppressing EGFR-positive lung cancer cells
Publication date: Available online 20 October 2023Source: Cancer LettersAuthor(s): Wei-Jyun Hua, Hsin Yeh, Zhi-Hu Lin, Ai-Jung Tseng, Li-Chen Huang, Wei-Lun Qiu, Tsung-Hsi Tu, Ding-Han Wang, Wei-Hung Hsu, Wei-Lun Hwang, Tung-Yi Lin